Skip to main content
Filing year 2024

WORLD CHILD CANCER USA

Golden, Colorado·EIN 46-0886328·NTEE G30 · Diseases, Disorders & Medical Disciplines·501(c)(3)
Total revenue
$538k
Total assets
$515k
Total expenses
$107k
Reported officers
6
Mission

TO IMPROVE CANCER DIAGNOSIS, TREATMENT AND CARE FOR CHILDREN ACROSS THE DEVELOPING WORLD

Reported officers (all unpaid)

No paid executives reported in 2024. WORLD CHILD CANCER USA reported 6 unpaid officers and board members on its 990.

Board Member
Board Member
Board Member
Board Member
Chairwoman
Treasurer

Funded by

Private foundations whose Form 990-PF Part XV grants matched this organization.

Financial trend

Revenue and expenses over time

WORLD CHILD CANCER USA reported revenue and expenses across 2 filing years.

RevenueExpenses
$72k
$102k
2023
$538k
$107k
2024
Total revenue and total expenses from IRS Form 990 filings.
Sector benchmark

What Diseases, Disorders & Medical Disciplines executives earn

WORLD CHILD CANCER USA reported no executive compensation in its latest filing. For context, the highest-paid executive at a comparable diseases, disorders & medical disciplines organization nationwide earns a median of $91,250.

25th percentile
$43k
Median
$91,250
75th percentile
$169k
90th percentile
$325k

These are diseases, disorders & medical disciplines sector-wide figures, not this organization's reported pay. Based on 2,397 organizations across 2,397 filings (2021 – 2024).

See full Diseases, Disorders & Medical Disciplines compensation data
FAQ

Common questions about WORLD CHILD CANCER USA

What are WORLD CHILD CANCER USA's revenue and expenses?

In 2024, WORLD CHILD CANCER USA reported $538k in total revenue and $107k in total expenses on its IRS Form 990.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.